Google AI ModeAug 29, 2026
CARB-X: If your biotech addresses drug-resistant bacterial infections, CARB-X provides non-dilutive funding
Loading…
AI summary
CARB-X accelerates global antibacterial innovation by supporting the development of new antibiotics and other products to combat drug-resistant bacteria.
AI named CARB-X from December 2025 to August 2026.
Question: I'm looking for non-dilutive funding for a biotech startup to cover clinical trials.
Google AI ModeAug 29, 2026
CARB-X: If your biotech addresses drug-resistant bacterial infections, CARB-X provides non-dilutive funding
